Literature DB >> 19547337

Unique interpretation of Talbot Bands and Fourier domain white light interferometry.

Adrian Gh Podoleanu.   

Abstract

A theoretical model is developed to interpret the output of the diffraction grating spectrometer used to analyze the channelled spectrum produced by a low coherence interferometer set-up. This model leads to an unique interpretation which covers both cases (i) of Talbot bands and (ii) of a Michelson interferometer used in most spectral interferometry set-ups for sensing as well as for Fourier domain optical coherence tomography (FDOCT). Explanation of Talbot bands visibility as well as the decay of sensitivity with depth, characteristic for FDOCT, is explained by considering the extension of the two wavetrains diffracted by the diffraction grating in the spectrometer.

Year:  2007        PMID: 19547337     DOI: 10.1364/oe.15.009867

Source DB:  PubMed          Journal:  Opt Express        ISSN: 1094-4087            Impact factor:   3.894


  4 in total

1.  Twenty-five years of optical coherence tomography: the paradigm shift in sensitivity and speed provided by Fourier domain OCT [Invited].

Authors:  Johannes F de Boer; Rainer Leitgeb; Maciej Wojtkowski
Journal:  Biomed Opt Express       Date:  2017-06-15       Impact factor: 3.732

2.  Towards simultaneous Talbot bands based optical coherence tomography and scanning laser ophthalmoscopy imaging.

Authors:  Manuel J Marques; Adrian Bradu; Adrian Gh Podoleanu
Journal:  Biomed Opt Express       Date:  2014-04-04       Impact factor: 3.732

3.  Recovering distance information in spectral domain interferometry.

Authors:  Adrian Bradu; Niels Møller Israelsen; Michael Maria; Manuel J Marques; Sylvain Rivet; Thomas Feuchter; Ole Bang; Adrian Podoleanu
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

4.  Frequency multiplexed long range swept source optical coherence tomography.

Authors:  Mantas Zurauskas; Adrian Bradu; Adrian Gh Podoleanu
Journal:  Biomed Opt Express       Date:  2013-05-02       Impact factor: 3.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.